MedTrace Logo

Circulating Biomarkers and Ventricular Tachyarrhythmia

NCT01892462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2017-04-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether levels of inflammatory markers in circulating blood can correlate with risk for dangerous heart rhythms. Patients with systolic heart failure, which has been shown to increase risk for dangerous heart rhythms, will be enrolled. All subjects will have an implantable cardioverter-defibrillator (ICD) in place, which allows regular evaluation of heart rhythm.

Conditions

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Daniel P Morin, MD MPH · Ochsner Medical Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892462 on ClinicalTrials.gov